HN2011001597A - Sintesis de morfina -6-glucoronido o de uno de sus derivados - Google Patents

Sintesis de morfina -6-glucoronido o de uno de sus derivados

Info

Publication number
HN2011001597A
HN2011001597A HN2011001597A HN2011001597A HN2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A HN 2011001597 A HN2011001597 A HN 2011001597A
Authority
HN
Honduras
Prior art keywords
grupo
glucoronide
derivatives
group
morfina
Prior art date
Application number
HN2011001597A
Other languages
English (en)
Inventor
Dlubala Alain
Ripoche Isabelle
Trecant Claire
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HN2011001597A publication Critical patent/HN2011001597A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE MORFINA -6- GLUCORONIDO O DE UNO DE SUS DERIVADOS, QUE COMPRENDEN LAS ETAPAS QUE CONSISTEN (II) EN HACER REACCIONAR UN COMPUESTO QUE RESPONDE A LA FORMULA (I) SIGUIENTE: EN LA QUE R1 REPRESENTA UN GRUPO CARBONILO, COR5CO O SO2R6SO2 CON UN DERIVADO DE ACIDO GLUCORONICO QUE RESPONDE A LA FORMULA SIGUEINTE (II): EN LA QUE PG REPRESENTA UN GRUPO ACETILO, ISOBUTIRILO, BENZOILO O PIVALOILO X REPRESENTA UN GRUPO TRIHALOGENOACETAMIDATO Y R4 REPRESENTA UN GRUPO ALQUILO (C1-C4) CARBOXILATO; EN PRESENCIA DE UN FUERTEMENTE BASICO, DESPUES (III) EN RECUPERAR EL PRODUCTO OBTENIDO EN LA ETAPA (II)
HN2011001597A 2008-12-10 2011-06-09 Sintesis de morfina -6-glucoronido o de uno de sus derivados HN2011001597A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806948A FR2939436B1 (fr) 2008-12-10 2008-12-10 Synthese de morphine-6-glucuronide ou de l'un de ses derives

Publications (1)

Publication Number Publication Date
HN2011001597A true HN2011001597A (es) 2013-09-09

Family

ID=40996840

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2011001597A HN2011001597A (es) 2008-12-10 2011-06-09 Sintesis de morfina -6-glucoronido o de uno de sus derivados

Country Status (31)

Country Link
US (1) US8258298B2 (es)
EP (1) EP2376496B1 (es)
JP (1) JP5619768B2 (es)
KR (1) KR20110091534A (es)
CN (1) CN102307876B (es)
AR (1) AR074513A1 (es)
AU (1) AU2009326906B2 (es)
BR (1) BRPI0923238A2 (es)
CA (1) CA2746428A1 (es)
CL (1) CL2011001398A1 (es)
CO (1) CO6390060A2 (es)
CR (1) CR20110307A (es)
EA (1) EA201170790A1 (es)
EC (1) ECSP11011100A (es)
ES (1) ES2470666T3 (es)
FR (1) FR2939436B1 (es)
HK (1) HK1163096A1 (es)
HN (1) HN2011001597A (es)
IL (1) IL213379A0 (es)
MA (1) MA32950B1 (es)
MX (1) MX337925B (es)
MY (1) MY152276A (es)
NI (1) NI201100116A (es)
NZ (1) NZ593342A (es)
PE (1) PE20110836A1 (es)
SG (1) SG172069A1 (es)
TN (1) TN2011000243A1 (es)
TW (1) TW201033218A (es)
UA (1) UA103643C2 (es)
WO (1) WO2010067007A2 (es)
ZA (1) ZA201104657B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020012248A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Novel naphthylenyl compounds for long-acting injectable compositions and related methods
WO2020012245A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
WO2020094634A1 (en) 2018-11-05 2020-05-14 Alkermes Pharma Ireland Limited Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) * 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
GB2339196B (en) 1997-04-14 2001-11-07 Salford Ultrafine Chem & Res Morphine derivatives
ES2185350T3 (es) * 1998-06-06 2003-04-16 Cenes Ltd Sintesis de morfina-6-glucuronido.
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
TWI255186B (en) * 2001-06-05 2006-05-21 Control Delivery Sys Inc Sustained-release analgesic compounds
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
KR20050008658A (ko) * 2002-03-19 2005-01-21 마이클 홀릭 아포모르핀의 글리코시드 및 오르토에스테르 글리코시드유도체들, 유사체들 및 그것의 용도
FR2864082B1 (fr) 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur

Also Published As

Publication number Publication date
FR2939436B1 (fr) 2010-12-17
EP2376496A2 (fr) 2011-10-19
TW201033218A (en) 2010-09-16
MY152276A (en) 2014-09-15
WO2010067007A2 (fr) 2010-06-17
AR074513A1 (es) 2011-01-19
JP2012511551A (ja) 2012-05-24
TN2011000243A1 (fr) 2012-12-17
MA32950B1 (fr) 2012-01-02
KR20110091534A (ko) 2011-08-11
MX337925B (es) 2016-03-28
HK1163096A1 (en) 2012-09-07
EA201170790A1 (ru) 2011-12-30
US8258298B2 (en) 2012-09-04
CN102307876B (zh) 2014-12-10
CO6390060A2 (es) 2012-02-29
ZA201104657B (en) 2012-09-26
ES2470666T3 (es) 2014-06-24
IL213379A0 (en) 2011-07-31
CL2011001398A1 (es) 2011-10-28
CA2746428A1 (fr) 2010-06-17
UA103643C2 (ru) 2013-11-11
BRPI0923238A2 (pt) 2016-01-26
JP5619768B2 (ja) 2014-11-05
AU2009326906B2 (en) 2016-05-26
MX2011006264A (es) 2011-11-04
SG172069A1 (en) 2011-07-28
PE20110836A1 (es) 2011-11-25
EP2376496B1 (fr) 2014-03-12
ECSP11011100A (es) 2011-07-29
US20110275820A1 (en) 2011-11-10
AU2009326906A1 (en) 2011-06-30
NZ593342A (en) 2013-07-26
FR2939436A1 (fr) 2010-06-11
CN102307876A (zh) 2012-01-04
WO2010067007A3 (fr) 2011-07-07
NI201100116A (es) 2011-12-14
CR20110307A (es) 2011-09-21

Similar Documents

Publication Publication Date Title
CY1121776T1 (el) C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων
CY1121744T1 (el) Παραγωγα c4-μονομεθυλο-τριτερπενοειδους και μεθοδοι χρησης αυτων
DK2057126T3 (da) Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater
EA200702614A1 (ru) Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
UY31523A1 (es) Procedimiento para la preparacion de esteres alquilicos de acidos grasos
NZ592497A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
WO2009129545A8 (en) Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
ECSP11011341A (es) Inhibidores de epoxicetona proteasa de tripéptidos cristalinos
CY1115043T1 (el) Φαρμακευτικο σκευασμα
NZ603268A (en) Process for synthesizing oxidized lactam compounds
MY150280A (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
HN2011001597A (es) Sintesis de morfina -6-glucoronido o de uno de sus derivados
CL2011000093A1 (es) Compuestos derivados de un ester piperidinilico del acido bifenil-2-ilcarbamico; composicion farmaceutica; combinacion farmaceutica; y su uso para broncoconstriccion, enfermedades obstructivas o inflamatorias de las vias respiratorias.
BRPI0814115B8 (pt) composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
IN2014MN00971A (es)
NO20084839L (no) Metoder for fremstilling av glutaminsyrederivater og melomprodukter
AR084209A1 (es) Metodo para la sintesis de derivados de aminociclohexanona sustituidos
CO6612175A2 (es) Metodo para producir 4,6-dialcoxi-2-cianometil-pirimidina e intermediarios sinteticos de esta